Live video detailing scores high marks with physicians

Share this article:
According to a new study by Manhattan Research, video detailing is now a viable option for pharma, biotech and device manufacturers. 

Manhattan Research's ePharma Physician v8.0 study found that the majority of physicians who have engaged in online video meetings with a pharma sales rep or cell center report that they are satisfied with the experience. 
The Manhattan Research report includes data and insights around the current state of physician video detailing adoption, demographics, behaviors, and satisfaction; market potential and future interests; delivery models and vendors; and strategic implementation best practices. 

The objective of the analysis is to provide pharmaceutical, biotech and device manufacturers with the market data and analysis for justifying strategic investment in video detailing and adapting and planning for the future of the physician-sales and company rep relationship. 

Monique Levy, senior director of research at Manhattan Research and author of the analysis said that video detailing has finally re-emerged as a viable marketing and service option, prompting manufacturers to take another look at this channel to connect with physicians. 

Levy added that video detailing users are some of the industry's most valuable and tech-savvy customers. 
Levy also said that beyond being highly adept at navigating in a multichannel environment, physicians who use video detailing are much more likely to write a larger volume of scripts and to have a higher weekly patient load than non-users of video detailing.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?